IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells

  title={IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells},
  author={Akiko Yagami and Kanami Orihara and Hideaki Morita and Kyoko Futamura and Noriko Hashimoto and Kenji Matsumoto and Hirohisa Saito and Akio Matsuda},
  journal={The Journal of Immunology},
  pages={5743 - 5750}
IL-33 is a member of the IL-1 family and mediates its biological effects via the ST2 receptor, which is selectively expressed on Th2 cells and mast cells. Although polymorphic variation in ST2 is strongly associated with asthma, it is currently unclear whether IL-33 acts directly on lung tissue cells at sites of airway remodeling. Therefore, we aimed to identify the IL-33–responsive cells among primary human lung tissue cells. ST2 mRNA was expressed in both endothelial and epithelial cells but… 

Figures from this paper

Interleukin-33 promotes inflammatory cytokine production in chronic airway inflammation.

IL-33 is a promoter of chronic airway inflammation that contributes to COPD development and could induce and enhance the expression of IL-6 and IL-8 in HBE cells and PBMCs of COPD patients via ST2/IL-1RacP pathway and MAPKs pathway.

Endogenous IL-33 enhances Th2 cytokine production and T-cell responses during allergic airway inflammation.

It is demonstrated that intra-nasal administration of IL-33 triggered an immediate allergic response in the airways, and more importantly, it is shown that endogenousIL-33 contributes to airway inflammation and peripheral antigen-specific responses in ovalbumin-induced acute allergic lung inflammation using IL- 33-deficient mice.

Contributions of IL-33 in Non-hematopoietic Lung Cells to Obstructive Lung Disease

Current knowledge of expression, induction, and function of IL-33 and its receptor ST2 in non-hematopoietic lung cells in the context of health and disease is summarized.

IL-33 and Airway Inflammation

IL-33 provides a unique therapeutic way for asthma, i.e., ameliorating innate airway inflammation by profoundly enhances allergic inflammation through increased expression of proallergic cytokines and chemokines.

Role of IL-33 in inflammation and disease

The role of IL-33 in the inflammation of several disease pathologies will be discussed, with particular emphasis on recent advances.

Role of IL-33 in allergic inflammation and diseases

IL-33 may be important in innate and adaptive Th2-type immune responses, however, the mechanisms for the synthesis, processing and release of IL-33 remain poorly understood.

The role of interleukin-33 in pathogenesis of bronchial asthma. New experimental data

The data is summarized and analyzed on the role of IL-33 in BA pathogenesis and the prospects for creating new treatments for BA.

Interleukin-33 biology with potential insights into human diseases

IL-33 has been shown to be involved in experimental models of arthritis and potentially has a pathogenic role in ulcerative colitis and fibrotic conditions, suggesting that IL-33 antagonists might be of interest for the treatment of asthma, rheumatoid arthritis and ulceratives colitis.

Interleukin-33 and ST2 Signaling in Tumor Microenvironment.

  • Jaewoo HongSoohyun KimP. Lin
  • Biology, Medicine
    Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research
  • 2019
The expression of IL-33/ST2 in cancer tissues shows a close association with tumor growth and tumor progression in several types of cancer, suggesting the IL- 33/ ST2 pathway as a potential target for therapy.

Interleukin-33 induces growth-regulated oncogene-α expression and secretion in human umbilical vein endothelial cells.

It is indicated that IL-33 localized in the human atherosclerotic plaque increases GRO-α mRNA expression and protein secretion via activation of ERK1/2, JNK, and NF-κB in HUVECs, suggesting that IL -33 plays an important role in the pathophysiology and development of atherosclerosis.



IL-33 can promote survival, adhesion and cytokine production in human mast cells

The hypothesis that IL-33 may enhance mast cell function in allergic disorders and other settings, either in the presence or absence of co-stimulation of mast cells via IgE/antigen–FcɛRI signals is supported.

Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production.

It is demonstrated that IL-33 promotes angiogenesis and vascular leakage by stimulating endothelial NO production via the ST2/TRAF6-Akt-eNOS signaling pathway, and open new perspectives for the role of IL- 33 in the pathogenesis of angiogenic-dependent and inflammatory vascular diseases.

ST2 gene expression is proliferation-dependent and its ligand, IL-33, induces inflammatory reaction in endothelial cells

ST2 gene was expressed in each of the vascular endothelial cell types tested, and the expression was growth-dependent and down-regulated when the cells were differentiated to form vascular structures on the extracellular membrane matrix.

A novel IL-1 family cytokine, IL-33, potently activates human eosinophils.

Increased Expression of IL-33 in Severe Asthma: Evidence of Expression by Airway Smooth Muscle Cells1

The data propose IL-33 as a novel inflammatory marker of severe and refractory asthma as well as subjects with asthma severity because ASMC are a source of the IL- 33 cytokine.

IL-33 Amplifies the Polarization of Alternatively Activated Macrophages That Contribute to Airway Inflammation1

It is demonstrated here that IL-33/ST2 plays a significant role in the amplification of AAM polarization and chemokine production which contribute to innate and Ag-induced airway inflammation.

IL-33-activated dendritic cells induce an atypical TH2-type response.

IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-41

It is demonstrated here that, in the presence of Ag, IL-33 induces IL-5-producing T cells and promotes airway inflammation independent of IL-4.

Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.

It is demonstrated that basophils and eosinophils are the only direct target leukocytes for IL- 33, suggesting that IL-33 promotes allergic inflammation and Th2 polarization mainly by the selective activation of these specialized cells of the innate immune system.

Cutting Edge: The ST2 Ligand IL-33 Potently Activates and Drives Maturation of Human Mast Cells1

It is reported that IL-33 directly stimulates primary human mast cells to produce several proinflammatory cytokines and chemokines and also exerts a permissive effect on the MCs response to thymic stromal lymphopoietin, a recently described potent MCs activator.